AGONIST FUSION PROTEIN FOR CD40 AND OX40 AND USES THEREOF
- 专利权人:
- Thomas Jefferson University
- 发明人:
- Mark L. Tykocinski,Matthew Charles Weber
- 申请号：
- US16726367
- 公开号：
- US20200239584A1
- 申请日:
- 2019.12.24
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- Provided is a fusion protein comprising an agonist for CD40 and an agonist for OX40. Compositions comprising the fusion protein and methods of use are also provided.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- POLYVALENT AND POLYSPECIFIC OX40-BINDING FILLED PROTEINS
- PROTEINES MONOSPECIFIQUES ET BISPECIFIQUES A ROLE DE REGULATION DE POINTS DE CONTROLE IMMUNITAIRE DESTINEES AU TRAITEMENT DU CANCER
- RECOMBINANT POXVIRAL VECTORS EXPRESSING BOTH RABIES AND OX40 PROTEINS, AND VACCINES MADE THEREFROM
- Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom
- Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom
